Announced Sun, 17 May · 10:16 IST

Newspaper Publication for Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2026

JLHL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.2%1-day move
₹1323.00
prior close
₹1335.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.9-2.2-2.6-2.9+1.2-0.2-1.2+2.7+2.6+0.2+1.5+1.9+17.8
Up moveDown movePending
AI summary

Jupiter Life Line Hospitals has published its Q4 FY26 and full year FY26 audited financial results. Standalone revenue grew 13% year-on-year to Rs 11,976 million, while consolidated revenue increased 15% to Rs 14,998 million. Standalone net profit rose 3.6% to Rs 1,914 million, with EPS at Rs 29.19. The Board declared an interim dividend of Rs 1 per share for FY 2025-26. Q4 standalone revenue stood at Rs 3,124 million. Results were approved at the Board meeting held on May 15, 2026.

Likely market impact

Steady revenue growth with modest profit increase. The 15% consolidated revenue growth reflects expansion in hospital operations. The modest ~3.6% rise in standalone net profit with higher revenue suggests some margin pressure. The dividend declaration is a positive signal for shareholders.